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Advanced Gastric Cancer and Perfusion
Imaging Using a Multidetector Row
Computed Tomography: Correlation with
Prognostic Determinants
Objective: To investigate the relationship between the perfusion CT features
and the clinicopathologically determined prognostic factors in advanced gastric
cancer cases.
Materials and Methods: A perfusion CT was performed on 31 patients with
gastric cancer one week before surgery using a 16-channel multi-detector CT
(MDCT) instrument. The data were analyzed with commercially available soft-
ware to calculate tumor blood flow (BF), blood volume (BV), mean transit time
(MTT), and permeability surface (PS). The microvessel density (MVD), was eval-
uated by immunohistochemical staining of the surgical specimens with anti-
CD34. All of the findings were analyzed prospectively and correlated with the clin-
icopathological findings, which included histological grading, presence of lymph
node metastasis, serosal involvement, distant metastasis, tumor, node, metasta-
sis (TNM) staging, and MVD. The statistical analyses used included the Student’s
t-test and the Spearman rank correlation were performed in SPSS 11.5.
Results: The mean perfusion values and MVD for tumors were as follows: BF
(48.14 16.46 ml/100 g/min), BV (6.70 2.95 ml/100 g), MTT (11.75 4.02 s),
PS (14.17 5.23 ml/100 g/min) and MVD (41.7 11.53). Moreover, a significant
difference in the PS values was found between patients with or without lymphatic
involvement (p = 0.038), as well as with different histological grades (p = 0.04)
and TNM stagings (p = 0.026). However, BF, BV, MTT, and MVD of gastric can-
cer revealed no significant relationship with the clinicopathological findings
described above (p > 0.05). 
Conclusion: The perfusion CT values of the permeable surface could serve as
a useful prognostic indicator in patients with advanced gastric cancer. 
ith a mortality rate as high as 25 in 100,000, the prognosis of gastric
cancer in China is very poor (1), and is closely related to TNM (tumor,
node, metastasis) staging, histological classification and differentiation,
lymphatic metastasis, as well as serosal infiltration (2, 3). Angiogenesis was originally
reported by Folkman (4) in 1971, as the process of new blood vessel development,
and reflects the generation of a new blood supply into tumor tissue that is now
regarded as a prognostic indicator for several tumors. Generally, a tumor is measured
by its microvessel density (MVD), which is a somewhat invasive technique, depending
on the availability of postoperative tissue or adequate biopsy material (5). 
Though multi-detector CT (MDCT) has been used for the staging of gastric
carcinoma, the morphological features could not reflect the physiologic tissue parame-
ters. Consequently, no adequate imaging modality has been reliable enough to predict
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Wprocedures and for trials of adjuvant chemotherapy. The
advent of spiral CT systems in the 1990s enabled perfusion
scans to be performed with MDCT, thus broadening the
technique’s availability, and permitting the measurement
of the tumor vascular physiology in the brain, lung, liver,
neck, and breast (6 8). The method could also be useful
for assessing risk-stratification and therapeutic monitoring
(9). Currently, the major clinical applications for perfusion
CTs include acute stroke and oncology cases, such as
tumor grading in cerebral glioma and lymphoma, and the
prediction of tumor response to radiotherapy (6, 10). The
relationship between the perfusion values and the progno-
sis of gastric cancer has, to the best of our knowledge, not
been reported. The purpose of this study was to evaluate
the relationship between perfusion CT and clinicopatholog-
ical features of gastric adenocarcinoma and its potential as
a novel prognostic predictor.
MATERIALS AND METHODS
Patients
Thirty one cases of pathologically proven gastric cancer
occurring from March 2002 to March 2005 were prospec-
tively included in this study. The patient records and the
pertinent clinical data are shown in Table 1 and include
tumor size (greatest diameter), pathological TNM (pTNM)
staging (UICC 1997) and WHO histological grading (11) as
described: well differentiated = an adenocarcinoma with
well-developed glands and often resembling a metaplastic
intestinal epithelium; moderately differentiated = an
adenocarcinoma intermediate between the well differenti-
ated and poorly differentiated; poorly differentiated = an
adenocarcinoma composed of highly irregular glands that
are recognized with difficulty, or single cells that remain
isolated or are arranged in small to large clusters with
mucin secretions or acinar structures. 
A CT perfusion was approved by the Hospital Ethics
Committee and a patient consent was obtained before
imaging. All tumors were resected via a surgical procedure
at one week after MDCT scanning (GE-Lightspeed, GE
Medical Systems, Milwaukee, WI). 
Perfusion CT Technique
Following a 1,000 1,200 ml oral dose of water, and a
20 mg intravenous injection of Scopolamine (Boehringer
Ingelheim, Germany), a perfusion scan was performed in a
16-section MDCT cine period lasting 60sec. The patients
were instructed to practice a gentle breathing technique
while scanning, and were fixed with an abdominal belt.
The lesion was localized on the non-enhanced CT scan
with a 2 cm tumor region of interest defined by an experi-
enced radiologist. The dynamic scan was acquired at this
level, performed at a static table position during an
intravenous bolus of 50 ml in nonionic iodinated contrast
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Table 1. Clinical Characteristics of the Patients (n = 31)
Sex Male 20
Female 11
Age 42 - 79 yr (mean 62 yr)
Size of tumor 3.3 - 8.4 cm (mean 4.2 cm)
Depth of invasion pT2 10
pT3 15
pT4 06
Nodal status N0 08
N1 08
N2 15





Histological grading moderately differentiated 12
poorly differentiated  19
Note. pTNM = pathological tumor, node, metastasis
Table 2. Perfusion Values in Gastric Cancer Compared with Histological Grade
Histological Grade Mean SD p value
Blood Flow (ml/100 g/min) poorly differentiated 50.159 15.611 0.499
moderately differentiated 44.119 20.180
Blood Volume (ml/100 g) poorly differentiated 07.127 04.161 0.433
moderately differentiated 05.837 02.357
Mean Transit Time (sec) poorly differentiated 11.682 04.981 0.916
moderately differentiated 11.903 05.786
Permeability Surface (ml/100 g/min) poorly differentiated 16.471 09.003 0.040
moderately differentiated 09.558 05.422
Microvessel Density (per/*400 field) poorly differentiated 44.150 14.203 0.178
moderately differentiated 34.900 10.875
Note. SD = standard deviationenhance medium (Iopromide, Ultravist300; Schering,
Berlin, Germany) via the antecubital vein at 4 5 ml/s. The
following parameters were used: 10 s for the scan delay
from the start of injection; 5 mm slice thickness
(reconstruction slice thicknesses were 5 mm and 10 mm); 1
s gantry rotation period with a 1 s temporal resolution; 120
kV, 100 mA and a 60 sec transverse data acquisition
period. Next, the data were transferred to a workstation
(Advantage Windows 4.0; perfusion 3.0; GE Medical
Systems) and analyzed using commercial software. The
advantages of the analytical method included a deconvolu-
tion for perfusion and blood volume, which demonstrated
good temporal resolution and high spatial resolution, while
high image noise and limited volume coverage appeared to
be its disadvantages. 
The abdominal artery was used as a partial-volume
averaging correction. Each region of interest, drawn over
the tumor by a radiologist section by section, was as large
as possible to reduce noise (> 50 pixels) and to almost
completely cover the whole lesion, with care to exclude
peripheral fat and necrotic area. Maps of tumor blood flow
(BF) (ml/100 g/min), blood volume (BV) (ml/100 g), mean
transit time (MTT) (sec), and permeability surface (PS)
(ml/100 g/min) were calculated automatically for all four
sections (with reconstruction slice thickness 5 mm)
available for each patient. The same process was repeated
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Table 4. Perfusion Values in Gastric Cancer Compared with Distant Metastasis
Distant Metastasis Mean SD p value
Blood Flow (ml/100g/min) 48.136 18.205 0.996
+ 48.194 10.921
Blood Volume (ml/100g) 6.506 2.717 0.585
+ 7.646 4.409
Mean Transit Time (sec) 12.089 5.609 0.488
+ 10.086 2.914
Permeability Surface (ml/100g/min) 13.444 8.322 0.322
+ 17.780 4.228
Microvessel Density (per/*400 field) 40.680 11.913 0.499
+ 43.000 12.435
Table 5. Perfusion Values in Gastric Cancer Compared with Lymphatic Metastasis and pTNM
Lymphatic Metastasis pTNM 
Coefficient p value Coefficient p value
Blood Flow  0.146 0.433 0.114 0.549
Blood Volume  0.185 0.327 0.086 0.651
Mean Transit Time  0.023 0.905 0.018 0.925
Permeability Surface 0.480 0.038 0.509 0.026
Microvessel Density 0.146 0.440 0.132 0.487
Note. SD = standard deviation, pTNM = pathological tumor node metastasis
Table 3. Perfusion Values in Gastric Cancer Compared with Serosal Involvement
Serosal Involvement Mean SD p value
Blood Flow (ml/100 g/min) 40.469 12.686 0.192
+ 51.984 19.568
Blood Volume (ml/100 g) 05.493 02.386 0.138
+ 07.799 02.568
Mean Transit Time (sec) 11.096 05.967 0.636
+ 12.085 05.015
Permeability Surface (ml/100g/min) 12.075 06.089 0.365
+ 15.213 05.015
Microvessel Density (per/*400 field) 38.300 13.573 0.551
+ 42.450 12.421in the sections where reconstruction of slice thickness was
10 mm. Moreover, the mean values were recorded for
further study.
Microvessel Staining and Evaluation
All patients were evaluated pathologically for histologic
diagnosis and MVD counting. The MVD was estimated by
immunohistochemical staining of the surgical specimens
with anti-CD34 monoclonal antibody (Dako, Copenhagen
Denmark) (12). 
The criteria for vessel counting were previously
established by Weidner et al. (13). Any single brown-
staining endothelial cell or small clusters of brown-staining
endothelial cells, with or without a lumen, are clearly
separated from its adjacent microvessels, tumor cells, and
other connective tissue elements considered as being
individual vessels. Vessels of a caliber larger than the
approximately eight red blood cells and vessels with a
thick muscular wall were excluded from the final counting.
The MVD counting was performed by a single pathologist. 
After screening the areas with intense neovascularized
spots in a low power field (40), the microvessels in the area
with the highest number of discrete microvessels were
counted in a 400x field. Moreover, three separate areas of
intense neovascularization were assessed for each sample
and the mean MVD was calculated for each tumor
evaluated. 
Statistical Analysis
The BV, BF, MTT, PS, and MVDs are expressed as the
mean standard deviation (SD) and the data were
subjected to a Kolmogorov-Smirnov normality test. All
findings were prospectively analyzed and were found to be
correlated with the clinicopathological results (histological
grading, presence of lymph node metastasis, serosal
involvement, TNM staging, and MVD). The statistical
analyses (t-test and Spearman rank correlation) were
calculated in SPSS 11.5 (SPSS Inc., Chicago, IL). For the
two-tailed tests, p-values less than 0.05 were considered
statistically significant. 
RESULTS
The perfusion parameters for gastric cancer in 31
patients (with reconstruction slice thicknesses of 5 and 10
mm) were compared, and revealed no significant differ-
ences (p > 0.3). In this study, the 5 mm reconstruction slice
thickness data was used for all statistical analyses. 
The mean perfusion values and MVD for tumors are as
follows: BF (48.14 16.46 ml/100 g/min), BV (6.70 2.95
ml/100 g), MTT (11.75 4.02 sec), and PS (14.17 5.23
ml/100 g/min) and MVD (41.7 11.53/400x field).
Moreover, the relationship between values and different
histological grades, serosal involvement, distant metastasis,
or lymphatic metastasis, and pTNM are detailed in Tables
2-5. A significant difference exists for the PS value
between patients with or without lymphatic involvement
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Fig. 1. Poorly differentiated gastric cancer. 
A. Cross section before contrast administration revealed protruding lesion classified as Borrmann I. Regions of interest have been
placed between abdominal aorta and lesion.
B. Corresponding time density curves show arterial and tumor attenuation change with time.Perfusion Imaging in Gastric Cancer and Correlation with Prognostic Determinants
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Fig. 1. C. Image calculating blood volume with mean value, 6.71
ml/100 g.
D. Image calculating blood flow with mean value, 73.64 ml/100
g/min.
E. Image calculating mean transit time with mean value, 10.45 sec.
F. Those values of lesion were rather lower; permeability surface
(mean, 18.49 ml/100 g/min) appeared to be rather high.
G. This patient had low microvessel density (mean, 21/*400 field).
EF
G
CD(p = 0.038), as well as among different histological grades
(p = 0.04) and TNM staging (p = 0.026). However, the BF,
BV, MTT, and MVD of gastric cancer revealed no signifi-
cant relationship with any clinicopathological features (p >
0.05) (Figs. 1, 2).
DISCUSSION
Currently, a perfusion CT is calculated by the deconvo-
lution approach, which is based on the theory that immedi-
ate enhancement of the tumor is largely due to the
presence of the contrast media within the intravascular
space and its first-pass to the extravascular space. With the
leakage to the extravascular space, the enhancement of the
tumors are caused by the contrast media in both the
intrasvascular and extravascular space (10). The deconvo-
lution model has the ability to tolerate greater image noise,
is therefore rather well suited to abdominal scans, and is
the preferred method for the measurement of low levels of
perfusion, which are applicable to gastrocarcinoma (14). 
No consensus has been reached regarding optimal scan
techniques in the published literature. The first item of
controversy and debate is the acquisition time. The
majority of the injected contrast media remains intravascu-
lar within 40 s (it is also affected by cardiac output and
central blood volume); however, a much greater propor-
tion later passes into the extravascular space. Eventually,
equilibrium is reached and the blood returns into the
intravascular space. The duration of this process lasts
around 2 to 4 min (15 17). A perfusion CT scan was
performed prospectively in 10 patients with histologically-
proven colorectal cancer using different acquisition times
(45, 60, and 130 s) by Goh et al. (18). No significant differ-
ence was found for BF, BV, or MTT values between any
acquisition times; however, significant differences in PS
were found between 45 sec and 65 or 130 sec. By measur-
ing the attenuation change within the input artery and
tumor, an IRF (input response function) curve can be
derived. The peak of this curve is regarded as BF, while
BV is represented by the area under the curve. As a result,
different acquisition times do not drastically affect these
three values since the shape of the curve is fixed. Although
the radiation dose in a perfusion CT scan is around 700
mGy (70% of abdominal CT), the extra 2 min dose may be
harmful to the patient and efforts should be taken to
minimize the dose. Furthermore, a long acquisition time
can lead to respiratory motion in an abdominal scan. When
taking all of these elements into account, we determined
that the 60 sec acquisition time be the most appropriate for
our study.
The 60 sec acquisition time would be very difficult to
diminish respiratory artifacts. It is most unlikely that the
patients will suspend respiration for 60 sec. Furthermore,
patients who suspend their breathing will often exhale,
which will lead to more motion artifacts and the tempta-
tion to take a deep breath when experiencing the “hot
flush” associated with a rapid bolus of contrast medium
will interrupt the perfusion scanning. Therefore, a quiet
respiration was requested during the scan, with patients in
the prone position and fixed with a waistline to reduce the
Zhang et al.
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Fig. 2. Poorly differentiated gastric cancer. 
A. Cross section prior to contrast administration revealed ulcerative lesion at antrum classified as Borrmann II.
B. Corresponding time density curves reveals arterial and tumor attenuation change with time
ABPerfusion Imaging in Gastric Cancer and Correlation with Prognostic Determinants
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EF
Fig. 2. C. Image calculating blood volume with mean value, 4.59
ml/100 g.
D. Image calculating blood flow with mean value, 100.45 ml/100
g/min.
E. Image calculating mean transit time with mean value, 4.1 sec.
F. Lesion values were lower; permeability surface (mean, 21.93
ml/100 g/min) was relatively high.
G. Patient had high microvessel density (mean, 61/*400 field).
G
CDextension of respiration (14).
Pathological TNM staging, histological grading, serosal
involvement, lymphatic metastasis, and MVD have been
identified as important predictors of the prognosis resulting
from gastric cancer in our study (19 20). Moreover,
pTNM is the conventional prognostic index as it reflects
the depth of invasion as well as lymphatic or distal
metastasis (3). Tumor outcome is determined by tumor
size, extent, stage, and biological behavior and is largely
described according to its histological grade. Recent studies
have acknowledged that the lymphatic metastasis status is
critical in the prognosis of gastric cancer. The mortality of
patients with lymphatic metastasis is 3.92x greater than
patients without lymphatic metastasis. Angiogenesis is a
highly complex phenomenon that is essential for the
growth of solid tumors, hence permitting rapid tumor
growth and increased potential for tumor metastasis.
Furthermore, angiogenesis is a significant predictor of
prognosis and hematogenous metastasis in patients with
gastric cancer. MVD is currently applied as an indicator of
tumor angiogenesis, and has further been demonstrated
that, in some tumors, up to 15% of tumor blood vessels
demonstrate the presence of cancer cells in the lumen (21).
It is proposed that these small, leaky vessels allow tumor
cells to reach the circulatory system, thus increasing the
probability of metastasis. The results of a multiple elements
analysis in breast cancer, indicated that MVD plays a more
important role in predicting invasion and metastases than
other clinical indicators. Also, several studies have shown a
positive statistical correlation between MVD and metasta-
sis in other solid tumors such as in the lung, uterus, cervix,
and prostate. However, the relationship is controversial in
gastric cancer (5, 22 24). 
According to the results of this study, there is a signifi-
cant difference for the PS value between patients with and
without lymphatic involvement. Moreover, there is also a
significant difference between different histological grades
and TNM stages, while BF, BV, MTT, and MVD revealed
no significant correlation with clinicopathological findings
for gastric cancer.
Permeability surface represents the transmission rate of
contrast media from capillary endothelium to interstitial
space, reflects the integrity of endothelial cells and
permeability of vessels. It is known that tumor capillaries,
in general, have wide inter-endothelial junctions, a large
number of fenestrate and transendocannels, and discontin-
uous or absent basement membrane. Compared to normal
vessels, they are more easily penetrated by large particles,
including tumor cells. This whole process often happens
along with an inflammatory reaction that accelerates
permeability changes (22, 25). Previous reports have put
too much emphasis on blood flow of the tumor rather than
the functional differences compared to normal vessels-
capillary permeability, which appears to be of value in
grading of cerebral glioma and lung cancer (13, 26). We
believe PS to be an indicator of prognosis in gastric cancer,
warranting further study in larger cohort of patients.
There is no significant difference in the BF, BV, MTT and
MVD between patients with and without lymphatic
involvement, but also with different histological grades and
TNM staging. The reasons for this may be as follows: First,
this may be due to the small size of the study population,
which contained many patients with poorly differentiated
carcinoma, which perhaps causes some statistical bias.
Second, elevated tissue pressure present at the center of
such tumors have caused the lumen and resulted in the
underestimation of the MVD (3). Third, it has been
suggested by Sahani et al. (10) that angiogenesis stimulates
the opening of significant numbers of arteriovenous shunts,
rather than producing a new vascular supply (10).
Anything above may affect the result of BF, BV and MTT
values. Moreover, different tumors have different
pathological features. Regional cerebral blood volume is
closely related to the grading of glioma (27). Fourth, tumor
vessels are structurally and functionally abnormal, with
uneven diameters, increased length and tortuosity,
multiple arteriovenous shunts, and loss of physiological
regulation of blood flow. The distribution of tumor vessels
is uneven, with a large amount in the vascular area and a
small amount in necrotic region. Because MVD is a direct
technique has a significant shortcoming as it depends on
the availability of postoperative tissue or biopsy materials.
Also, different areas will present different densities.
Additionally, a gastric ulcer is associated with cancer, thus
complicating accurate calculation (28). Fifth, there is the
possibility that MVD acts as an indicator of angiogenesis
correlates hematogeneous metastasis. 
Several limitations exist in our study. First, as the size of
the study population was too small, no estimation of the
absolute value of PS data could be provided for under a
clinical analysis. Second, too many patients with poorly
differentiated carcinoma lead to statistic bias. Third, the
lack of control group in the study is another limitation, the
normal gastric wall is more likely to be too thin for us to
achieve perfusion CT values. Fourth, a respiratory artifact
is something hard to overcome, especially for a 60 sec free
breathing scan. It may interfere with the results. Fifth,
extraradiation dose of CT perfusion is harmful and we
should minimize it. It has been reported that MRI could aid
in optimizing treatments, categorizing lesions, and
influencing patient care in brain tumors (26), which might
be a hint for the futher investigation in gastrointestinal
Zhang et al.
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In summary, perfusion CT is a reproducible, objective,
and feasible imaging strategy for the evaluation of
oncology. Furthermore, the analysis of perfusion CT in
gastric cancer (especially for the PS value), might be a
helpful prognostic indicator, or as being useful for predict-
ing the response to clinical treatment. 
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